Acidosis Drives Damage-associated Molecular Pattern (DAMP)-induced Interleukin-1 Secretion via a Caspase-1-independent Pathway

被引:57
作者
Edye, Michelle E. [1 ]
Lopez-Castejon, Gloria [1 ]
Allan, Stuart M. [1 ]
Brough, David [1 ]
机构
[1] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
Acidosis; Caspase; Glia; Inflammation; Innate Immunity; Interleukin; Stroke; STERILE INFLAMMATORY RESPONSE; RECEPTOR ANTAGONIST; NLRP3; INFLAMMASOME; DEFICIENT MICE; IL-1-BETA; CELLS; PH; IL-1-ALPHA; ARTHRITIS; ISCHEMIA;
D O I
10.1074/jbc.M113.478941
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
070307 [化学生物学]; 071010 [生物化学与分子生物学];
摘要
The proinflammatory cytokine IL-1 is a key mediator of inflammatory responses that contribute to and exacerbate brain injury. IL-1 is synthesized by microglia in the brain as an inactive precursor (pro-IL-1). Cleavage of pro-IL-1 to a mature form is stimulated by damage-associated molecular patterns (DAMPs). These DAMPs are sensed by a pattern recognition receptor called NLRP3, which forms an inflammasome, resulting in the activation of caspase-1 and cleavage of pro-IL-1. To date, regulation of the inflammasome in culture has been studied under normal culture conditions, and it is not known how DAMPs signal under disease relevant conditions such as acidosis. Given the presence of acidosis in pathological states, our objective was to test the hypothesis that acidic conditions modify DAMP-induced IL-1 release from cultured primary mouse glial cells. When LPS-primed glial cells were stimulated with DAMPs under acidic conditions (pH 6.2), the predominant IL-1 form secreted was the 20-kDa rather than the 17-kDa caspase-1-dependent species. Lactic acidosis, induced by the addition of 25 mm lactic acid, also induced the release of 20-kDa IL-1. This 20-kDa product was produced independently of NLRP3 and caspase-1 but was inhibited by the cathepsin D inhibitor pepstatin A. These data suggest that under disease relevant acidosis, DAMPs and lactic acid induce the secretion of IL-1 independently of the inflammasome. Therapeutic strategies directed to the inhibition of IL-1 processing should therefore consider alternative processing of IL-1 in addition to caspase-1-dependent processing.
引用
收藏
页码:30485 / 30494
页数:10
相关论文
共 33 条
[1]
Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1α [J].
Afonina, Inna S. ;
Tynan, Graham A. ;
Logue, Susan E. ;
Cullen, Sean P. ;
Bots, Michael ;
Luethi, Alexander U. ;
Reeves, Emer P. ;
McElvaney, Noel G. ;
Medema, Jan P. ;
Lavelle, Ed C. ;
Martin, Seamus J. .
MOLECULAR CELL, 2011, 44 (02) :265-278
[2]
Interleukin-1 and neuronal injury [J].
Allan, SM ;
Tyrrell, PJ ;
Rothwell, NJ .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (08) :629-640
[3]
Global Indicators and Targets for Noncommunicable Diseases [J].
Angell, S. Y. ;
Danel, I. ;
DeCock, K. M. .
SCIENCE, 2012, 337 (6101) :1456-1457
[4]
Inflammatory microcrystals alter the functional phenotype of human osteoblast-like cells in vitro:: Synergism with IL-1 to overexpress cyclooxygenase-2 [J].
Bouchard, L ;
de Médicis, R ;
Lussier, A ;
Naccache, PH ;
Poubelle, PE .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :5310-5317
[5]
Role of IL-1α and IL-1β in ischemic brain damage [J].
Boutin, H ;
LeFeuvre, RA ;
Horai, R ;
Asano, M ;
Iwakura, Y ;
Rothwell, NJ .
JOURNAL OF NEUROSCIENCE, 2001, 21 (15) :5528-5534
[6]
Sterile inflammation: sensing and reacting to damage [J].
Chen, Grace Y. ;
Nunez, Gabriel .
NATURE REVIEWS IMMUNOLOGY, 2010, 10 (12) :826-837
[7]
Blocking interleukin-1β in acute and chronic autoinflammatory diseases [J].
Dinarello, C. A. .
JOURNAL OF INTERNAL MEDICINE, 2011, 269 (01) :16-28
[8]
Anti-inflammatory Agents: Present and Future [J].
Dinarello, Charles A. .
CELL, 2010, 140 (06) :935-950
[9]
A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients [J].
Emsley, HCA ;
Smith, CJ ;
Georgiou, RF ;
Vail, A ;
Hopkins, SJ ;
Rothwell, NJ ;
Tyrrell, PJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (10) :1366-1372
[10]
Fantuzzi G, 1997, J IMMUNOL, V158, P1818